A new model of glaucoma filtering surgery in the rat

Journal of Glaucoma

Volumn 13, Issue 5, 2004, Pages 407-412

  Sherwood, M B ^a   Esson, D W ^a   Neelakantan, A ^a   Samuelson, D A ^b  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b University of Florida   (United States)

Author keywords

Glaucoma filtering surgery; Rat model

Indexed keywords

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANNULA; CONJUNCTIVA; FILTERING OPERATION; GLAUCOMA; GLAUCOMA SURGERY; HISTOLOGY; INTRAOCULAR PRESSURE; NONHUMAN; PRIORITY JOURNAL; RAT; SCLERA; SUTURE; TREATMENT OUTCOME; WOUND HEALING;

ANIMALS; BLISTER; CATHETERIZATION; CONJUNCTIVA; CONNECTIVE TISSUE; FILTERING SURGERY; GLAUCOMA; MALE; MODELS, ANIMAL; POSTOPERATIVE PERIOD; RATS; RATS, SPRAGUE-DAWLEY; TIME FACTORS;

EID: 4644336532     PISSN: 10570829     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ijg.0000131482.86547.5a     Document Type: Article

References (60)

1. Roodhooft JM. Leading causes of blindness worldwide. Bull Soc Belge Ophtalmol. 2002;283:19-25.
2. Coleman AL, Brigatti L. The glaucomas. Minerva Med. 2001;92:365-379.
3. Taylor HR, Keeffe JE. World blindness: a 21st century perspective. Br J Ophthalmol. 2001;85:261-266.
4. Addicks EM, Quigley A, Green WR, et al. Histologic characteristics of filtering blebs in glaucomatous eyes. Arch Ophthalmol. 1983;101:795-798.
5. Hitchings RA, Grierson I. Clinico pathological correlation in eyes with failed fistulizing surgery. Trans Ophthalmol Soc U K. 1983;103:84-88.
6. Lama PJ, Fechtner RD. Antifibrotics and wound healing in glaucoma surgery. Surv Ophthalmol. 2003;48:314-346.
7. Skuta GL. Antifibrotic agents in glaucoma filtering surgery [review]. Int Ophthalmol Clin. 1993;33:165-182.
8. Rockwood EJ, Parrish RK 2nd, Heuer DK, et al. Glaucoma filtering surgery with 5-fluorouracil. Ophthalmology. 1987;94:1071-1078.
9. Stamper RL, McMenemy MG, Lieberman MF. Hypotonous maculopathy after trabeculectomy with subconjunctival 5-fluorouracil. Am J Ophthalmol. 1992;114:544-553.
10. Jampel HD, Pasquale LR, Dibernardo C. Hypotony maculopathy following trabeculectomy with mitomycin C (letter). Arch Ophthalmol. 1992; 110:1049-1050.
11. Greenfield DS, Liebmann JM, Jee J, et al. Late-onset bleb leaks after glaucoma filtering surgery. Arch Ophthalmol. 1998;16:443-447.
12. Mietz H, Addicks K, Bloch W, et al. ng-term intraocular toxic effects of topical mitomycin C in rabbits. J Glaucoma. 1996;5:325-333.
13. Wolner B, Liebmann JM, Sassani JW, et al. Late bleb-related endophthalmitis after trabeculectomy with adjunctive 5-fluorouracil. Ophthalmology. 1991;98:1053-1060.
14. Waheed S, Liebmann JM, Greenfield DS, et al. Recurrent bleb infections. Br J Ophthalmol. 1998;82:926-929.
15. Soltau JB, Rothman RF, Budenz DL, et al. Risk factors for glaucoma filtering bleb infections. Arch Ophthalmol. 2000;118:338-342.
16. Tsou R, Cole JK, Nathens AB, et al. Analysis of hypertrophic and normal scar gene expression with cDNA microarrays. J Burn Care Rehabil. 2000; 21:541-550.
17. Lo WR, Rowlette LL, Caballero M, et al. Tissue differential microarray analysis of dexamethasone induction reveals potential mechanisms of steroid glaucoma. Invest Ophthalmol Vis Sci. 2003;44:473-485.
18. Hernandez MR, Agapova OA, Yang P, et al. Differential gene expression in astrocytes from human normal and glaucomatous optic nerve head analyzed by cDNA microarray. Glia. 2002;38:45-64.
19. Wiechmann AF. Regulation of gene expression by melatonin: a microarray survey of the rat retina. J Pineal Res. 2002;33:178-185.
20. Varela JC, Goldstein MH, Baker HV, et al. Microarray analysis of gene expression patterns during healing of rat corneas after excimer laser photorefractive keratectomy. Invest Ophthalmol Vis Sci. 2002;43:1772-1782.
21. Richey KJ, Engrav LH, Pavlin EG, et al. Topical growth factors and wound contraction in the rat: Part I. Literature review and definition of the rat model. Ann Plast Surg. 1989;23:159-165.
22. Engrav LH, Richey KJ, Kao CC, et al. Topical growth factors and wound contraction in the rat: Part II. Platelet-derived growth factor and wound contraction in normal and steroid-impaired rats. Ann Plast Surg. 1989;23: 245-248.
23. Young W. Spinal cord contusion models [review]. Prog Brain Res. 2002; 137:231-255.
24. Meddahi A, Caruelle JP, Gold L, et al. New concepts in tissue repair: skin as an example [review]. Diabetes Metab. 1996;22:274-278.
25. Ashhurst DE. Collagens synthesized by healing fractures [review]. Clin Orthop. 1990;255:273-283.
26. Fini ME, Girard MT, Matsubara M. Collagenolytic/gelatinolytic enzymes in corneal wound healing [review]. Acta Ophthalmol Suppl. 1992;202: 26-33.
27. Yamada J, Dana MR, Sotozono C, et al. Local suppression of IL-1 by receptor antagonist in the rat model of corneal alkali injury. Exp Eye Res. 2003;76:161-167.
28. Wolde-Mussie E, Yoles E, Schwartz M, et al. Neuroprotective effect of memantine in different retinal injury models in rats. J Glaucoma. 2002; 11:474-480.
29. Cordeiro MF, Constable PH, Alexander RA, et al. Effect of varying the mitomycin-C treatment area in glaucoma filtration surgery in the rabbit. Invest Ophthalmol Vis Sci. 1997;38:1639-1646.
30. Gwin TD, Stewart WC, Gwynn DR. Filtration surgery in rabbits treated with diclofenac or prednisolone acetate. Ophthalmic Surg. 1994;25:245-250.
31. Doyle JW, Sherwood MB, Khaw PT, et al. Intraoperative 5-fluorouracil for filtration surgery in the rabbit. Invest Ophthalmol Vis Sci. 1993;34: 3313-3319.
32. Wilson AS, Hobbs BG, Speed TP, et al. The microarray: potential applications for ophthalmic research. Mol Vis. 2002;8:259-270.
33. Wang P, Ding F, Chiang H, et al. ProbeMatchDB-a web database for finding equivalent probes across microarray platforms and species. Bioinformatics. 2002;18:488-489.
34. Birney E, Clamp M, Hubbard T. Databases and tools for browsing genomes. Annu Rev Genomics Hum Genet. 2002;3:293-310.
35. Sheridan CM, Unger WG, Ayliffe W, et al. Macrophages during fibrosis following scleral fistulising surgery in a rat model. Curr Eye Res. 1996; 15:559-568.
36. Hanna KD, Pouliquen YM, Savoldelli M, et al. Corneal wound healing in monkeys 18 months after excimer laser photorefractive keratectomy. Refract Corneal Surg. 1990;6:340-345.
37. Gressel MG, Parrish RK 2nd, Folberg R. 5-fluorouracil and glaucoma filtering surgery: I. An animal model. Ophthalmology. 1984;91:378-383.
38. Bair JS, Chen CW. Trabeculectomy with multiple applications of mitomycin-C in monkeys with experimental glaucoma. J Ocul Pharmacol Ther. 1997;13:115-128.
39. Hasty B, Heuer DK, Minckler DS. Primate trabeculectomies with 5-fluorouracil collagen implants. Am J Ophthalmol. 1990;109:721-725.
40. Connon CJ, Meek KM. Organization of corneal collagen fibrils during the healing of trephined wounds in rabbits. Wound Repair Regen. 2003;11: 71-78.
41. Gao J, Gelber-Schwalb TA, Addeo JV, et al. Apoptosis in the rabbit cornea after photorefractive keratectomy. Cornea. 1997;16:200-208.
42. Schultz G, Khaw PT, Oxford K, et al. Growth factors and ocular wound healing [review]. Eye. 1994;8:184-187.
43. Lloyd MA, Baerveldt G, Nguyen QH, et al. Long-term histologic studies of the Baerveldt implant in a rabbit model. J Glaucoma. 1996;5:334-339.
44. Miller MH, Grierson I, Unger WI, et al. Wound healing in an animal model of glaucoma fistulizing surgery in the rabbit. Ophthalmic Surg. 1989;20:350-357.
45. Tahery MM, Lee DA. Review: pharmacologic control of wound healing in glaucoma. J Ocul Pharmacol. 1989;5:155-179.
46. Khaw PT, Occleston NL, Schultz G, et al. Activation and suppression of fibroblast function. Eye. 1994;8:188-195.
47. Esson D, Schultz G, Sherwood M, et al. Expression of connective tissue growth factor (CTGF) after glaucoma filtration surgery in a rabbit model. IOVS, in press.
48. Parekh T, Saxena B, Reibman J, et al. Neutrophil chemotaxis in response to TGF-beta isoforms (TGF-beta 1, TGF-beta 2, TGF-beta 3) is mediated by fibronectin. J Immunol. 1994;152:2456-2466.
49. Cordeiro M, Bhattacharya S, Schultz G, et al. TGF-β1, -β2 and -β3 in vitro: biphasic effects on Tenon's fibroblast contraction, proliferation and migration. Invest Ophthalmol Vis Sci. 2000;41:756-763.
50. Pena RA, Jerdan JA, Glaser BM. Effects of TGF-beta and TGF-beta neutralizing antibodies on fibroblast-induced collagen gel contraction: implications for proliferative vitreoretinopathy. Invest Ophthalmol Vis Sci. 1994;35:2804-2808.
51. Frazier K, Williams S, Kothapalli D, et al. Stimulation of fibroblast cell growth, matrix production, and granulation tissue formation by connective tissue growth factor. J Invest Dermatol. 1996;107:404-411.
52. Duncan MR, Frazier KS, Abramson S, et al. Connective tissue growth factor mediates transforming growth factor beta-induced collagen synthesis: down-regulation by cAMP. FASEB J. 1999;13:1774-1786.
53. Grotendorst GR. Connective tissue growth factor: a mediator of TGF-beta action on fibroblasts [review]. Cytokine Growth Factor Rev. 1997;8:171-179.
54. Ihn H. Pathogenesis of fibrosis: role of TGF-beta and CTGF. Curr Opin Rheumatol. 2002;14:681-685.
55. Kucich U, Rosenbloom JC, Herrick DJ, et al. Signaling events required for transforming growth factor-beta stimulation of connective tissue growth factor expression by cultured human lung fibroblasts. Arch Biochem Biophys. 2001;395:103-112.
56. Leask A, Holmes A, Black CM, et al. Connective tissue growth factor gene regulation. Requirements for its induction by transforming growth factor-beta 2 in fibroblasts. J Biol Chem. 2003;278:13008-13015.
57. Cordeiro MF, Mead A, Ali RR, et al. Novel antisense oligonucleotides targeting TGF-beta inhibit in vivo scarring and improve surgical outcome. Gene Ther. 2003;10:59-71.
58. Cordeiro MF, Gay JA, Khaw PT. Human anti-transforming growth factor-beta2 antibody: a new glaucoma anti-scarring agent. Invest Ophthalmol Vis Sci. 1999;40:2225-2234.
59. Reichel MB, Cordeiro MF, Alexander RA, et al. New model of conjunctival scarring in the mouse eye. Br J Ophthalmol. 1998;82:1072-1077.
60. Mietz H, Chevez-Barrios P, Lieberman MW. A mouse model to study the wound healing response following filtration surgery. Graefes Arch Clin Exp Ophthalmol. 1998;236:467-475.